1 - 25 of 31 results for author:"de Verneuil H." in Literature citations
Results Customize
› Repeat search in UniProtKB (9)
| Loss of epidermal hypoxia-inducible factor-1alpha accelerates epidermal aging and affects re-epithelialization in human and mouse. Rezvani H.R., Ali N., Serrano-Sanchez M., Dubus P., Varon C., Ged C., Pain C., Cario-Andre M., Seneschal J., Taieb A. et al. J. Cell. Sci. 124:4172-4183(2011) · Mapped (3) |
| A prospective study of filaggrin null mutations in keratoconus patients with or without atopic disorders. Droitcourt C., Touboul D., Ged C., Ezzedine K., Cario-Andre M., de Verneuil H., Colin J., Taieb A. Dermatology (Basel) 222:336-341(2011) · Mapped (10) |
| ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria. To-Figueras J., Ducamp S., Clayton J., Badenas C., Delaby C., Ged C., Lyoumi S., Gouya L., de Verneuil H., Beaumont C. et al. Blood 118:1443-1451(2011) · UniProtKB (2) |
| HIF-1alpha in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders. Rezvani H.R., Ali N., Nissen L.J., Harfouche G., de Verneuil H., Taieb A., Mazurier F. J. Invest. Dermatol. 131:1793-1805(2011) · Mapped (9) |
| XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Rezvani H.R., Rossignol R., Ali N., Benard G., Tang X., Yang H.S., Jouary T., de Verneuil H., Taieb A., Kim A.L. et al. Biochim. Biophys. Acta 1807:609-619(2011) · Mapped (14) |
| XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. Rezvani H.R., Kim A.L., Rossignol R., Ali N., Daly M., Mahfouf W., Bellance N., Taieb A., de Verneuil H., Mazurier F. et al. J. Clin. Invest. 121:195-211(2011) · Mapped (14) |
| A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. Soufir N., Ged C., Bourillon A., Austerlitz F., Chemin C., Stary A., Armier J., Pham D., Khadir K., Roume J. et al. J. Invest. Dermatol. 130:1537-1542(2010) · Mapped (14) |
| The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity. James C., Mazurier F., Dupont S., Chaligne R., Lamrissi-Garcia I., Tulliez M., Lippert E., Mahon F.X., Pasquet J.M., Etienne G. et al. Blood 112:2429-2438(2008) · Mapped (6) |
| Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Hubiche T., Ged C., Benard A., Leaute-Labreze C., McElreavey K., de Verneuil H., Taieb A., Boralevi F. Acta Derm. Venereol. 87:499-505(2007) · Mapped (18) |
| Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. Rezvani H.R., Dedieu S., North S., Belloc F., Rossignol R., Letellier T., de Verneuil H., Taieb A., Mazurier F. J. Biol. Chem. 282:16413-16422(2007) · Mapped (9) |
| Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice. Lyoumi S., Abitbol M., Andrieu V., Henin D., Robert E., Schmitt C., Gouya L., de Verneuil H., Deybach J.C., Montagutelli X. et al. Blood 109:811-818(2007) · Mapped (6) |
| Protective effects of catalase overexpression on UVB-induced apoptosis in normal human keratinocytes. Rezvani H.R., Mazurier F., Cario-Andre M., Pain C., Ged C., Taieb A., de Verneuil H. J. Biol. Chem. 281:17999-18007(2006) · Mapped (3) |
| A knock-in mouse model of congenital erythropoietic porphyria. Ged C., Mendez M., Robert E., Lalanne M., Lamrissi-Garcia I., Costet P., Daniel J.Y., Dubus P., Mazurier F., Moreau-Gaudry F. et al. Genomics 87:84-92(2006) · Mapped (8) |
| Congenital erythropoietic porphyria: report of a novel mutation with absence of clinical manifestations in a homozygous mutant sibling. Ged C., Megarbane H., Chouery E., Lalanne M., Megarbane A., de Verneuil H. J. Invest. Dermatol. 123:589-591(2004) · UniProtKB (1) |
| Description of a new mutation in hepatoerythropoietic porphyria and prenatal exclusion of a homozygous fetus. Ged C., Ozalla D., Herrero C., Lecha M., Mendez M., de Verneuil H., Mascaro J.M. Arch. Dermatol. 138:957-960(2002) · UniProtKB (1) |
| Congenital erythropoietic porphyria: a novel homozygous mutation in a Japanese patient. Rogounovitch T., Takamura N., Hombrados I., Morel C., Tanaka T., Kameyoshi Y., Shimizu-Yoshida Y., de Verneuil H., Yamashita S. J. Invest. Dermatol. 115:1156-1156(2000) · UniProtKB (1) |
| Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT. Christiansen L., Ged C., Hombrados I., Broens-Poulsen J., Fontanellas A., de Verneuil H., Hoerder M., Petersen N.E. Hum. Mutat. 14:222-232(1999) · UniProtKB (1) |
| A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. Mazurier F., Fontanellas A., Salesse S., Taine L., Landriau S., Moreau-Gaudry F., Reiffers J., Peault B., Di Santo J.P., de Verneuil H. J. Interferon Cytokine Res. 19:533-541(1999) · Mapped (7) |
| Novel point mutation in the uroporphyrinogen III synthase gene causes congenital erythropoietic porphyria of a Japanese family. Takamura N., Hombrados I., Tanigawa K., Namba H., Nagayama Y., de Verneuil H., Yamashita S. Am. J. Med. Genet. 70:299-302(1997) · UniProtKB (1) |
| A novel point mutation in congenital erythropoietic porphyria in two members of Japanese family. Tanigawa K., Bensidhoum M., Takamura N., Namba H., Yamashita S., de Verneuil H., Ged C. Hum. Genet. 97:557-560(1996) · UniProtKB (1) |
| Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Moran-Jimenez M.J., Ged C., Romana M., de Salamanca R.E., Taieb A., Topi G., D'Alessandro L., de Verneuil H. Am. J. Hum. Genet. 58:712-721(1996) · UniProtKB (1) |
| Ferrochelatase structural mutant (Fechm1Pas) in the house mouse. Boulechfar S., Lamoril J., Montagutelli X., Guenet J.-L., Deybach J.-C., Nordmann Y., Dailey H., Grandchamp B., de Verneuil H. |
| Molecular cloning, sequencing, and functional expression of a cDNA encoding human coproporphyrinogen oxidase. Martasek P., Camadro J.-M., Delfau-Larue M.H., Dumas J.B., Montagne J.J., de Verneuil H., Labbe P., Grandchamp B. Proc. Natl. Acad. Sci. U.S.A. 91:3024-3028(1994) · UniProtKB (2) · Mapped (1) |
| The cDNA sequence of mouse uroporphyrinogen III synthase and assignment to mouse chromosome 7. Bensidhoum M., Ged C.M., Poirier C., Guenet J.-L., de Verneuil H. |
| Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene. Grandchamp B., de Verneuil H., Beaumont C., Chretien S., Walter O., Nordmann Y. Eur. J. Biochem. 162:105-110(1987) · UniProtKB (1) |